In this episode of Denatured, you'll be listening to Indu Navar, CEO and founder of EverythingALS and Dr. Olga Uspenskaya, ...

Palliative care physician, Dr. Mapa, and ALS researcher, Dr. Leitner, comment on the life and death for patients with ALS as well as future researchers.

Higher levels of blood lactate may be the key to a longer life for people with the neurodegenerative condition ALS, new ...

This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS ...

- The Expanded Access Program is funded by a grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Accelerating Access to Critical Therapies for ALS (ACT for ALS) ...

ALS Association yearly report cards show no U.S. state earned the highest score for policies supporting patients; several had failing grades.

The U.S. Congress greenlit a historic $315 million in federal ALS research funding for 2026 amid Rare Disease Month, spotlighting biotech progress like VectorY Therapeutics' first patient dosing in ...

Allowing people with disabilities to talk by just thinking about a word, that's what UC Davis researchers hope to accomplish with new cutting-edge technology. It can be a breakthrough for people with ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Researchers have found that patients with amyotrophic lateral sclerosis have ...

The 'Grey's Anatomy' star died on Thursday, Feb. 19, less than a year after being diagnosed with the disease ...

Amyotrophic lateral sclerosis, or ALS, is a rare nervous system disease. Here's what we know about bulbar ALS, which WHO's Jeriann Ritter may have.